اخبار و اعلانات

 آمار

تعداد نشریات286
تعداد نشریات سازمان84
تعداد شماره‌ها2,848
تعداد مقالات32,322
تعداد مشاهده مقاله41,448,203
تعداد دریافت فایل اصل مقاله18,648,896
Al-Rawi, M, Al-Mudallal, N. H. A. L, Taha, A. A. (1400). Determination of Ferrous Oxide Nanoparticles Minimum Inhibitory Concentration against Local Virulent Bacterial Isolates. سامانه مدیریت نشریات علمی, 76(4), 795-808. doi: 10.22092/ari.2021.355997.1758
M Al-Rawi; N. H. A. L Al-Mudallal; A. A Taha. "Determination of Ferrous Oxide Nanoparticles Minimum Inhibitory Concentration against Local Virulent Bacterial Isolates". سامانه مدیریت نشریات علمی, 76, 4, 1400, 795-808. doi: 10.22092/ari.2021.355997.1758
Al-Rawi, M, Al-Mudallal, N. H. A. L, Taha, A. A. (1400). 'Determination of Ferrous Oxide Nanoparticles Minimum Inhibitory Concentration against Local Virulent Bacterial Isolates', سامانه مدیریت نشریات علمی, 76(4), pp. 795-808. doi: 10.22092/ari.2021.355997.1758
Al-Rawi, M, Al-Mudallal, N. H. A. L, Taha, A. A. Determination of Ferrous Oxide Nanoparticles Minimum Inhibitory Concentration against Local Virulent Bacterial Isolates. سامانه مدیریت نشریات علمی, 1400; 76(4): 795-808. doi: 10.22092/ari.2021.355997.1758

Determination of Ferrous Oxide Nanoparticles Minimum Inhibitory Concentration against Local Virulent Bacterial Isolates

Archives of Razi Institute
مقاله 10، دوره 76، شماره 4، آذر و دی 2021، صفحه 795-808    اصل مقاله (811.45 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2021.355997.1758
نویسندگان
M Al-Rawi1؛ N. H. A. L Al-Mudallal* 1؛ A. A Taha2
1Department of Medical Microbiology, College of Medicine, Al-Iraqia University, Baghdad, Iraq
2Department of Applied Science, Division of Biotechnology, University of Technology, Baghdad, Iraq
چکیده
The improvement of multi-resistance properties of the bacterial pathogen has recently been discussed as an emerging issue. In this regard, iron oxide nanoparticles have attracted the researchers’ attention due to their wide application in the realm of medicine. Iron oxide nanoparticles have a high specific surface area that enables them to interact with the bacterial surface structure and has considerable antibacterial activity. The current study aimed to synthesize a novel antimicrobial agent from iron oxide nanoparticles and determine its minimum inhibitory concentration (MIC) on different gram-positive and negative variant bacterial strains isolated and characterized from the infected urinary tract of Iraqi elderly patients. This study was conducted from September 2020 to December 2020 on 75 urine samples collected from the infected urinary tract of elderly patients in the ages range of 60-75 years admitted to Al-Yarmouk Medical Hospital, Baghdad, Iraq. Isolation of bacterial isolates was carried out using differential and selective media. Afterward, they were characterized and confirmed using different biochemical tests and VITEK 2 system, respectively. Magnetic nanoparticles were fabricated by co-precipitation of ferric ions (Fe3+) and ferrous ions (Fe2+) in presence of ammonium hydroxide solution (25%). The characterization of synthesized nanoparticles was performed subsequently using UV-VIS spectroscopy analysis, Scanning Electron Microscope (SEM), Fourier transform infrared spectroscopy analysis, X-ray Diffraction analysis (XRD), and Energy-dispersive X-ray spectrum (EDX). The MIC of synthesized sonicated Fe3O4NP against different bacterial strains was determined using the broth culture dilution method through making serial dilutions of 50, 100, 200, 400, 500, 600, 800, 900 µg/ml from a 5mg/ml nanoparticle stock solution. Afterward, the lowest concentration of nanoparticles required to arrest the growth of bacteria was determined through the colony-forming unit of each treated bacteria on brain heart infusion agar. In total, 17bacterial isolates were identified from the infected urinary tract, five bacterial isolates (E. coli, Pseudomanas aeruginosa, Staphylococcus aureus, Enterococcus faecalis, and Micrococcus luteus). In addition, two Proteus mirabilis strains were identified separately and were tested against synthesized Fe3O4NP to determine the MIC. The novel synthesized antibacterial agent showed excellent bioactivity, compared with controls (consisting of bacterial suspension without ferrous oxide nanoparticles), and the synthesized antibacterial agent was considered significantly active against all the bacterial strains at a p-value less than 0.05. The Fe3O4NP were active against gram-negative more than gram-positive bacteria. The MIC of synthesized and characterized Fe3O4NPwas applied on seven gram-positive and negative bacterial isolates using bacteria- Fe3O4NP complex. Significant effects were observed on all strains, compared with controls, and this complex could significantly inhibit gram-negative more than gram-positive bacteria.
کلیدواژه‌ها
Iron Oxide NPs؛ Bacterial Strains؛ UTI Elderly Patients؛ Minimum inhibitory concentration
سایر فایل های مرتبط با مقاله
مراجع
  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37-49.
  2. Tektook NK, Al-Lehibi KI, Al-Husseinei RK. Prevalence some pathogenic bacteria causing uti in diabetic patients in/specialized center for endocrinology and diabetes of baghdad city–iraq. Med J Babylon. 2017;14(2):260-6.
  3. Cotter M, Donlon S, Roche F, Byrne H, Fitzpatrick F. Healthcare-associated infection in Irish long-term care facilities: results from the First National Prevalence Study. J Hosp Infect. 2012;80(3):212-6.
  4. Curns AT, Holman RC, Sejvar JJ, Owings MF, Schonberger LB. Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med. 2005;165(21):2514-20.
  5. Aljanaby AAJ, Medhat AR. Research article prevalence of some antimicrobials resistance associated-genes in Salmonella typhi isolated from patients infected with typhoid fever. J Biol Sci. 2017;17(4):171-84.
  6. Naderi A, Kasra-Kermanshahi R, Gharavi S, Fooladi AAI, Alitappeh MA, Saffarian P. Study of antagonistic effects of Lactobacillus strains as probiotics on multi drug resistant (MDR) bacteria isolated from urinary tract infections (UTIs). Iran J Basic Med Sci. 2014;17(3):201.
  7. Nigussie D, Amsalu A. Prevalence of uropathogen and their antibiotic resistance pattern among diabetic patients. Turk J Urol. 2017;43(1):85.
  8. Bakhshi B, Dehghan-Mouriaabadi A, Kiani P. Heterogeneity of multidrug-resistant Salmonella enterica isolates with increasing frequency of resistance to Ciprofloxacin during a 4-year period in Iran. Microb Drug Resist. 2018;24(4):479-88.
  9. Das R, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M. Antimicrobial susceptibility of bacteria isolated from urine samples obtained from nursing home residents. Infect Control Hosp Epidemiol. 2009;30(11):1116-9.
  10. Das S, Diyali S, Vinothini G, Perumalsamy B, Balakrishnan G, Ramasamy T, et al. Synthesis, morphological analysis, antibacterial activity of iron oxide nanoparticles and the cytotoxic effect on lung cancer cell line. Heliyon. 2020;6(9):e04953.
  11. Ismail RA, Sulaiman GM, Abdulrahman SA, Marzoog TR. Antibacterial activity of magnetic iron oxide nanoparticles synthesized by laser ablation in liquid. Mater Sci Eng C. 2015;53:286-97.
  12. Khatami M, Aflatoonian MR, Azizi H, Mosazade F, Hoshmand A, Nobre MAL, et al. Evaluation of antibacterial activity of iron oxide nanoparticles against Escherichia coli. practice. 2017;18:19.
  13. Khatami M, Alijani H, Sharifi I, Sharifi F, Pourseyedi S, Kharazi S, et al. Leishmanicidal activity of biogenic Fe3O4 nanoparticles. Sci Pharm. 2017;85(4):36.
  14. Cohen ML. Changing patterns of infectious disease. Nature. 2000;406(6797):762-7.
  15. Huang Z, Zheng X, Yan D, Yin G, Liao X, Kang Y, et al. Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir. 2008;24(8):4140-4.
  16. Masadeh MM, Karasneh GA, Al-Akhras MA, Albiss BA, Aljarah KM, Al-Azzam SI, et al. Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria. Cytotechnology. 2015;67(3):427-35.
  17. M Tille P. Bailey & Scott’s Diagnostic Microbiology Fourteenth Edition. Elsevier; 2017.
  18. Al-Mudallal N. H. A. L., Khudair A. M., AlsakiniA.l H. , N.A. Z. Molecular detection and Phylogenetic analysis of 16s RNA gene of Proteus mirabilis isolated from different clinical sources in Baghdad hospitals. 2021.
  19. Alzahrani E. Gum Arabic-coated magnetic nanoparticles for methylene blue removal. Int J Innov Res Sci Eng Technol. 2014;3(8):15118-29.
  20. Khashan KS, Jabir MS, Abdulameer FA. Carbon Nanoparticles decorated with cupric oxide Nanoparticles prepared by laser ablation in liquid as an antibacterial therapeutic agent. Materials Research Express. 2018;5(3):035003.
  21. Rashed MM, Al-Mudallal NH, Taha AA. Reduce the toxicity of prepared copper sulfide nanoparticles. Int J Pharm Sci. 2019;10(3):2099-103.
  22. Pua F-L, Chia CH, Zakari S, Liew TK, Yarmo MA, Huang NM. Preparation of transition metal sulfide nanoparticles via hydrothermal route. Sains Malays. 2010;39(2):243-8.
  23. Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences: Wiley; 2018.
  24. Wayne W, Daniel D, Chad L. Biostatistics. Basic concepts and methodology for the health sciences. New Delhi:. 2010.
  25. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005:643-54.
  26. Nicolle LE, Committee SL-TC. Urinary tract infections in long-term–care facilities. nfect Control Hosp Epidemiol. 2001;22(3):167-75.
  27. High KP, Juthani-Mehta M, Quagliarello VJ. Infectious diseases in the nursing home setting: challenges and opportunities for clinical investigation. Clin Infect Dis. 2010;51(8):931-6.
  28. Abdulrahman IS. Antimicrobial scesuptibility pattern of pathogenic bacteria causing urinary tract infection at Azadi hospital in Duhok city, Kurdistan region, Iraq. Sci J Univ Zakho. 2018;6(2):46-50.
  29. Yassin NA. Laboratory evaluation of urine culture and drug resistance in outpatients clincally suspected of urinary tract infections. Rawal Medical J. 2012;37:268-72.
  30. Hasany S, Ahmed I, Rajan J, Rehman A. Systematic review of the preparation techniques of iron oxide magnetic nanoparticles. Nanosci Nanotechnol. 2012;2(6):148-58.
  31. Huber DL. Synthesis, properties, and applications of iron nanoparticles. Small. 2005;1(5):482-501.
  32. Amendola V, Riello P, Meneghetti M. Magnetic nanoparticles of iron carbide, iron oxide, iron@ iron oxide, and metal iron synthesized by laser ablation in organic solvents. J Phys Chem C. 2011;115(12):5140-6.
  33. Estelrich J, Escribano E, Queralt J, Busquets MA. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int J Mol Sci. 2015;16(4):8070-101.
  34. Mohapatra M, Anand S. Synthesis and applications of nano-structured iron oxides/hydroxides–a review. Int J Eng Sci Technol. 2010;2(8).
  35. Hyeon T. Chemical synthesis of magnetic nanoparticles. Chem Commun. 2003(8):927-34.
  36. Xu J, Sun J, Wang Y, Sheng J, Wang F, Sun M. Application of iron magnetic nanoparticles in protein immobilization. Molecules. 2014;19(8):11465-86.
  37. Bao S, Li K, Ning P, Peng J, Jin X, Tang L. Highly effective removal of mercury and lead ions from wastewater by mercaptoamine-functionalised silica-coated magnetic nano-adsorbents: behaviours and mechanisms. Appl Surf Sci. 2017;393:457-66.
  1. Armijo LM, Wawrzyniec SJ, Kopciuch M, Brandt YI, Rivera AC, Withers NJ, et al. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms. J Nanobiotechnology. 2020;18(1):1-27.
  2. Li F, Liang Z, Liu J, Sun J, Hu X, Zhao M, et al. Dynamically reversible iron oxide nanoparticle assemblies for targeted amplification of T1-weighted magnetic resonance imaging of tumors. Nano Lett. 2019;19(7):4213-20.
  3. Madhu G, Jaianand K, Rameshkumar K, Eyini M, Balaji P, Veeramanikandan V. Solanum tuberosum extract mediated synthesis and characterization of iron oxide nanoparticles for their antibacterial and antioxidant activity. J Drug Deliv Sci Technol. 2019;9(1-s):5-15.
  4. Prodan AM, Iconaru SL, Chifiriuc CM, Bleotu C, Ciobanu CS, Motelica-Heino M, et al. Magnetic properties and biological activity evaluation of iron oxide nanoparticles. J Nanomater. 2013;2013.
  5. Taylor E, Webster TJ. Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine. 2011;6:1463.
  6. Gordon T, Perlstein B, Houbara O, Felner I, Banin E, Margel S. Synthesis and characterization of zinc/iron oxide composite nanoparticles and their antibacterial properties. Colloid Surf A-Physicochem Eng Asp 2011;374(1-3):1-8.
44.          Van Acker H, Gielis J, Acke M, Cools F, Cos P, Coenye T. The role of reactive oxygen species in antibiotic-induced cell death in Burkholderia cepacia complex bacteria. PloS one. 2016;11(7):e0159837. 

آمار
تعداد مشاهده مقاله: 1,818
تعداد دریافت فایل اصل مقاله: 646


counter
سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب